We examined normal and abnormal fibrinogen (fibrinogen "Grenoble") by two-dimensional gel electrophoresis to obtain data on possibledefects at the molecularlevel. Fibrinogen Grenoble is characterized by an abnormal rate of fibrin monomer aggregation. The electrophoretic analysis revealed the presence of abnormal y chains. Two kinds of y chains can be detected in fibrinogenGrenoble:(a) normal y chains and (b) y chains Grenoble (YG) with a greater molecular mass but no modification in isoelectric point. The latter chain can be detected in whole plasma by two-dimensional gel electrophoresis. Metrological analysis was performed in an attempt to quantify observed differences between normal fibnnogenand fibrinogenGrenoble. On use of gels stained either with Coomassie BrilliantBlue or with silver, the partly qualified evaluation gives about 60% normal y chain and 40% y chain Grenoble.
involve either different degrees of sulfation and phosphorylation or variations in neuraminic acid content (4, 5) .
Dysfibrinogenemia is a generic designation for inherited abnormal molecular fonns of fibrinogen, which are distinguished by addition of the name of the city in which they were first discovered. The molecular abnormality may alter the proteolytic activation by thrombin, the polymerization stage, or the stabilization by factor XIUa (6) . Fibrinogen Grenoble is one such abnormal fibrinogen. We have characterized it by investigations of the biochemical properties offibrinogen and by two-dimensional gel electro-
phoresis(2-D GE).
The latter revealed the molecular abnormality of fibrinogen Grenoble. Then, in an attempt to evaluate quantitatively the differences visually observed in spots from normal and fibrinogen Grenoble, we performed a metrological study: digitalized examination of 2-D gels.
Propositus, Materials, and Methods

Case summary.
A 61-year-old white woman was referred to a hematologist because of abnormal results for routine clotting tests revealing hypofibrinogenemia.
No other disorders were evident. Hepatic function was normal. Results of clinical examination were normal. There was no history of abnormal bleeding or thromboembolism (three pregnancies, with one miscarriage).
Shortly after these tests she had pelvic surgery for prolapse with urinary incontinence, with no complications: no bleeding, no thrombosis, and normal wound healing.
Sample collection.
Venous blood was collected in onetenth volume of a 38 g/L solution of trisodium citrate. Plasma was separated by centrifugation (3000 x g, 20 mm). Coagulation studies were either performed without delay or samples were stored at -70 #{176}C, with thawing at 37#{176}C just before assay. For fibrinogen purification, plasma was obmined by plasmapheresis.
Blood clotting. Most of the coagulation tests were routine ones (7). Fibrinogen was determined in plasma by different methods: by heat precipitation (8), kinetically (9), and immunologically (10).
Biochemical characterization.
Fibrinogen was purified according to Blomback and Bl#{246}mback (11). The final buffer was Ti-is HC1 (50 mmol/L, pH 7.5) containing 100 mmol of NaC1 per liter. Fibrinogen concentration was determined spectrophotometrically (e u,,, = 1.55). "Clottability" was determined by measuring the difference in A before and after coagulation induced by thrombin. Fibrin polymerization was studied by recording the transmittancy at 350 nm (12) . Either plasma or purified fibrinogen was used. Fibrin monomers were obtained as described by Gralnick et al. (13) which was a 20 mmoIlL solution of sodium hydroxide. The anolyte was 10 mmolJL phosphoric acid. Focusing was for 10 000 V h.
For the DALT dimension, we used homogeneous 100 g/L acrylamide gels. 'so gels were equilibrated in 4 mL of the SDS mixture (per liter, 100 g of glycerol, 20 g of sodium dodecyl sulfate, 1.3 g of dithioerythritol,
125 mmol of Ti-is) for 30 mm. The gels were stored at -70 #{176}C after equilibration and thawed at 37 #{176}C immediately before being applied to the top of the DALT gels.
For staining we used either Coomassie Brilliant Blue or the silver staining method of Oakley et al. (21). After staining, the gels were soaked in 20 g/L aqueous glycerol and dried under reduced pressure.
Digitalization.
For our metrological studies of dried 2-D gels we used an Optronics film scanner, 100 x 100 mgrid, for digitalization.
Each pixel yielded a byte (256gray levels are possible).
Results
Biochemical characterization.
The only coagulation test for which results were abnormal was that for fibrin formation. The concentration of fibrinogen in the plasma was significantly abnormal when measured by heat precipitation or kinetically ( Table 1) . For other tests the values were normal.
Clottability
at an ionic strength of 150 mmol/L was estimated to be 61% for purified propositus fibrinogen vs 94% for normal fibrinogen. Decreasing the ionic strength increased the clottability of fibrinogen Grenoble to 89% at 37.5 mmollL.
Curves for normal plasma and plasma from the propositus, for fibrin polymerization induced by thrombin, were quite different. Indeed, the polymerization reaction of the control plasma was over before that of the propositus' plasma has started.
Curves for polymerization of purified fibrinogen Grenoble showed only a subnormal rate and a lower final absorbance, but at an ionic strength of 75 mmol/ L the kinetic proffle was almost within normal limits. Fibrin monomers also aggregated at a decreased rate and the final absorbance was lower than for the control. Measurement of release of fibrinopeptide A showed no difference between normal fibrinogen and fibrinogen Grenoble. SOS-PAGE analysis did not reveal any significant differences for fibrin crosslinking by factor XIlla. Fibrinogen degradation products obtained by plasmin proteolysis did not exhibit detectable changes.
2-D GE analysis
of fibrinogen was the only technique by which we could reveal directly the nature of the fibrinogen Grenoble abnormality (Figure 1) , showing important differences between normal fibrinogen and fibrinogen Grenoble. The Aa and B/3 chains were almost identical with respect to molecular mass and isoelectric point, but the y chains were split into two, showing normal y and y' chains as well as abnormal YG and Y'G chains. The abnormal y and y'c chains showed no change in isoelectric point, but their molecular mass was greater than normal. The difference in molecular mass between y and YG chains and between / and 1 chains seemed to be identical (1200 to 1300 Da).
Between YGand YG chains we found the same increase in molecular mass as between y and y' chains, about 2200 Da. The splitting of y chains was also visible in 2-D GE of whole plasma, even when the Aa and B/3 chains were not well resolved.
Metrological study of fibrinogen
Grenoble. Figure 2 shows the diagram of a gel and an identification for each spot.
Gels stained with Coomassie Brilliant
Blue. Using purified fibrinogen, we measured absorbance in the 0 to 2 A range. Gray level 0 corresponds to 0 A for the background; gray level 100 corresponds to 0.78 A for the darkest spots. Possible gray levels range from 0 to 255, so the entire dynamics of measure was not used. Weakly stained parts of the gels were not detected and therefore do not appear on digitalized images. This was sometimes the case for Aa2 chains and spot 1 from B/3 chain, and always so for the y' chain variant. It was also true for streaks between spots. For each visible spot, the sum of the gray levels was computed for its whole surface. Theoretically, this value is proportional to the quantity of protein if the amount of protein-bound dye is proportional to the quantity of protein. Table 2 gives the results we obtained for chains Aa, B/3, and y on three gels F-NORM 1, 2, and 3 (from normal fibrinogen) and on three gels F-GRE 1, 2, and 3 (from fibrinogen Grenoble). These results were normalized, assuming the sum of gray levels for each chain to be equal to 100. In Table 2 , the results for the Aa, B/3, and y chains show fluctuations from one gel to another. Evaluation of scanner reproducibility showed that these variations are indeed ascribable to the gels themselves.
We estimate that the YG chain makes up about 40% of the total y chain of fibrinogen.
For F-NORM 3 and F-GRE 2, where all the spots were available, the sum of gray levels was computed. Table 3 shows these values normalized, based on the total sum of gray levels (Aa + B + y) being equal to 100.
Silver-stained gels. Using purified fibrinogen and plasma, we measured these gels in the 0 to 3 A range. The values Control cover the whole measurement dynamics. Anything visible to the eye on the gels would appear also on the digitalized images, including the weakest spots, streaks, and other
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ized on the basis of the sum window being equal to 100.
Table5 shows the ratios be ults for Act,B, and y chains fibrinogen) and two gels FIii GE of plasma' y chains are located in a region where These results were normaloiily few proteins are revealed. Act and Bf3 chains are much of gray levels of the same more (hffiC.Ult to identi1r. Thus the abnormality in fibrinogen Grenoble can be directly detected.
tween chains (we normalized SUIO5 of gray levels (normalized) are shown in Table 6 . Totalwindow: Sum of gray levels in a window, including the spots of the whole cflain. ': non-exploitablespots. a Mean values are data from Table 3 for CoomassieBlue staining, and from Table 5 mass ofthe YG and y' chains is about 1250 Da greater than that of normal y and y' chains, probably because of an elongated polypeptidic sequence in both YG and VG chains. Because there is both an abnormal y chain and a polymerization defect, the elongation of the y chains might be confined to the C-terminal part, which is involved in fibrin monomer aggregation. The C-terminal part of normal y chains is also involved in the stabilization by factor XllIa.
Because fibrinogen Grenoble shows normal stabilization, the portion of abnormal elongation responsible for it should then differ from the portion responsible for the stabilization.
In our metrological analysis, we attempted to quantify the three kinds of chains-Aa, Bf3, and '-in purified normal fibrinogen and fibrinogen Grenoble after use oftwo staining techniques, dye and silver staining. For technical reasons, not all spots were so exploitable:
artefacts on images (background, streaks) or variations on individual gels. Some data are thus incomplete (Aag chains or)' chain variant), and this study concerns the main spots.
Results
differ according to staining procedure. Table 7 shows, for each chain, the ratios of staining with Coomassie Brilliant Blue or silver. Theoretically, these ratios should be identical for each chain. For fibrinogen Grenoble the partly qualified evaluation gives about 40% of YG chain and 60% of normal y chain and reveals an heterozygous status. This analysis was also performed with normal plasma and plasma Grenoble. We have tried to quantify spots of fibrinogen y chains. The ratios differ somewhat from those obtained with purified fibrinogens, but they remain within the limit of error of the measurement.
We conclude that our study describing the characterization of a molecular variant of a plasma protein by 2-D GE provides another example of the potential of this highresolution technique (22,23). The detection is even possible with whole plasma as the sample. Once the parameters of reproducibility are well controlled in 2-D GE, reliable results can be obtained relatively quickly.
